Immunologic Studies of High Risk Groups


NIH 1992 N01 CP	Immunologic Studies of High Risk Groups Vedbrat, Sharanjit S. / Braton Biotech, Inc.
NIH 1988 N01 CP	Immunologic Studies of High Risk Groups Vedbrat, Sharanjit S. / Braton Biotech, Inc.
NIH 1987 N01 CP	Immunologic Studies of High Risk Groups Vedbrat, Sharanjit S. / Braton Biotech, Inc.
NIH 1987 N01 CP	Immunologic Studies of High Risk Groups Vedbrat, Sharanjit S. / Braton Biotech, Inc.
NIH 1986 N01 CP	Immunologic Studies of High Risk Groups Vedbrat, Sharanjit S. / Braton Biotech, Inc.
NIH 1985 N01 CP	Immunologic Studies of High Risk Groups Vedbrat, Sharanjit S. / Braton Biotech, Inc.

Mann, D L; Read-Connole, E; Arthur, L O et al. (1988) HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens. J Immunol 141:1131-6